Tilray expands cannabis flower production in Germany
Executive Summary
- Tilray Medical announced the launch of five new high‑THC “Tilray Craft” cannabis flower products in Germany, produced at its EU‑GMP certified facility in Neumünster.
- The expansion broadens Tilray’s premium craft cannabis offering for German physicians and pharmacies, reinforcing its commitment to patient‑centered medical cannabis solutions.
- All new products are immediately available by prescription throughout Germany, supporting the company’s growth strategy in the European market.
Key Details
- New Products Launched:
- Tilray Craft Cannabisbluten THC30 TRM (Triangle Mints)
- Tilray Craft Cannabisbluten THC28 TRM (Triangle Mints)
- Tilray Craft Cannabisbluten THC28 PPV (Platinum Pave 34)
- Tilray Craft Cannabisbluten THC25 PPV (Platinum Pave 34)
-
Tilray Craft Cannabisbluten THC22 SNS (Sunset Sherbet)
-
Production Facility: EU‑GMP certified plant in Neumünster, Germany, part of the BfArM in‑country cultivation program.
-
Availability: All five products are prescription‑only and can be dispensed at pharmacies across Germany immediately upon announcement.
-
Strategic Rationale: Expands Tilray’s high‑potency flower portfolio to meet evolving patient needs, enhances market presence in Europe, and leverages the company’s advanced manufacturing capabilities.
-
Executive Comment: Rajnish Ohri, Managing Director, International, highlighted the expansion as a demonstration of Tilray’s commitment to “patient care” and “consistent, quality solutions” for German physicians and pharmacies.
Notable Quotes
“The expansion of our Tilray Craft premium cannabis flower range demonstrates our commitment to patient care in Germany… Our priority remains delivering consistent, quality solutions to physicians and pharmacies, always placing patients' needs first.” – Rajnish Ohri, Managing Director, International, Tilray Brands.